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Background: Several studies indicate that people of the Fulani ethnic group are less susceptible to malaria
compared to those of other ethnic groups living sympatrically in Africa, including the Dogon ethnic group.
Although the mechanisms of this protection remain unclear, the Fulani are known to have higher levels of
Plasmodium falciparum-specific antibodies of all Ig classes as compared to the Dogon. However, the proportions of
B cell subsets in the Fulani and Dogon that may account for differences in the levels of Ig have not been
characterized.
Methods: In this cross-sectional study, venous blood was collected from asymptomatic Fulani (n = 25) and Dogon
(n = 25) adults in Mali during the malaria season, and from P. falciparum-naïve adults in the U.S. (n = 8). At the time
of the blood collection, P. falciparum infection was detected by blood-smear in 16% of the Fulani and 36% of the
Dogon volunteers. Thawed lymphocytes were analysed by flow cytometry to quantify B cell subsets, including
immature and naïve B cells; plasma cells; and classical, activated, and atypical memory B cells (MBCs).
Results: The overall distribution of B cell subsets was similar between Fulani and Dogon adults, although the
percentage of activated MBCs was higher in the Fulani group (Fulani: 11.07% [95% CI: 9.317 – 12.82]; Dogon: 8.31%
[95% CI: 6.378 – 10.23]; P = 0.016). The percentage of atypical MBCs was similar between Fulani and Dogon adults
(Fulani: 28.3% [95% CI: 22.73 – 34.88]; Dogon: 29.3% [95% CI: 25.06 – 33.55], but higher than U.S. adults (U.S.: 3.0%
[95% CI: -0.21 - 6.164]; P< 0.001). Plasmodium falciparum infection was associated with a higher percentage of
plasma cells among Fulani (Fulani infected: 3.3% [95% CI: 1.788 – 4.744]; Fulani uninfected: 1.71% [95% CI:
1.33 – 2.08]; P = 0.011), but not Dogon adults.
Conclusion: These data show that the malaria-resistant Fulani have a higher percentage of activated MBCs
compared to the Dogon, and that P. falciparum infection is associated with a higher percentage of plasma cells in
the Fulani compared to the Dogon, findings that may account for the higher levels of P. falciparum antibodies in
the Fulani.Background
Several studies have demonstrated that individuals of the
Fulani ethnic group in West Africa are at lower risk of
malaria and tend to have lower Plasmodium falciparum
parasite densities compared to individuals of other ethnic
groups living sympatrically with the Fulani, including the
Dogon [1]. Although protective mechanisms among the
Fulani remain unclear, many investigators have consist-
ently shown that the Fulani have higher levels of antibodies* Correspondence: pcrompton@niaid.nih.gov
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reproduction in any medium, provided the orspecific for P. falciparum antigens expressed at the liver
and blood stages [1-5], and enhanced IgG1 and IgG3 sub-
class and IgM antibody responses to malaria [6]. The B cell
biology underlying these observations is not understood.
It is now well established that long-term antibody
responses require the generation and maintenance of
memory-B cells (MBCs) and long-lived plasma cells
(LLPCs), defined in humans by the cell surface markers
CD19+CD27+CD38− and CD19+CD27++CD38+++, re-
spectively (reviewed in [7-9]). The process of generating
MBCs and LLPCs begins when naïve B cells encounter
their cognate antigen near the interface of B and T cell
areas of secondary lymphoid tissue, which drives naïve Bl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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plasma cells (SLPCs) within the extra-follicular region,
which contributes to the initial control of infections. Al-
ternatively, naïve B cells enter follicles where germinal
centers are formed, and after a period of 7–10 days, dur-
ing which the CD4+ T-cell-dependent process of affinity
maturation and immunoglobulin class-switching occurs,
the germinal center reaction yields LLPCs and MBCs of
higher affinity than the initial wave of SLPCs. LLPCs mi-
grate to the bone marrow where they constitutively se-
crete antibody and provide a critical first line of defense
against re-infection, whereas MBCs recirculate and me-
diate recall antibody responses after re-exposure to their
cognate antigen by rapidly proliferating and differentiat-
ing into plasma cells.
Recently, it was reported that P. falciparum exposure
in Malian children and adults, as well as Peruvian adults
[10], is associated with an expansion of a phenotypically
distinct population of MBCs identified as CD10− CD19+
CD20+ CD21− CD27−, similar to a MBC subpopulation
initially identified in healthy US individuals in mucosal-
associated lymphoid tissues by expression of the inhibi-
tory receptor Fc-receptor-like-4 (FCRL4) [11]. B cells
with a similar phenotype have been identified in indivi-
duals infected with HIV [12] and HCV [13]. Moir et al
showed that compared to naïve B cells and classical
MBCs, FCRL4+ MBCs proliferated less well in response
to BCR-cross-linking and/or to CD40L and Toll-like re-
ceptor 9 (TLR9) agonist CpG, and showed a decreased
ability to differentiate into antibody secreting cells in re-
sponse to polyclonal stimulation [12]. FCRL4+ MBCs in
HIV-viremic [12] and P. falciparum-exposed individuals
[11] also express high levels of inhibitory receptors and a
profile of lymphoid-homing receptors similar to that
expressed on exhausted CD8+ T cells during chronic
viral infections [14]. Given that the function of FCRL4+
MBCs in P. falciparum-exposed individuals is unknown,
we refer to this B cell subset in the context of malaria as
‘atypical’ rather than ‘exhausted’.
Here, the proportion of peripheral blood B cells that are
immature and naïve B cells; plasma cells; and classical,
activated, and atypical MBCs are compared in Fulani and
Dogon adults [1], and further comparisons of these B
cell subsets in asymptomatic P. falciparum infected and
uninfected individuals from both ethnic groups are
presented.
Methods
Mali study site and participants
This cross-sectional study was done in October 2008 in
Mantéourou, Mali, a rural village approximately 850 km
north of the capital of Bamako. A detailed description of
the study site has been published elsewhere [1]. Partici-
pants were randomly selected from an ongoing cohortstudy which has been described in detail elsewhere [1].
Plasmodium falciparum transmission is seasonal and in-
tense at this site from July through December. The ento-
mological inoculation was approximately 17 infective
bites/person/month in September of 2000. This cross-
sectional study includes 50 adults enrolled in October
2008. As is typical in Mali, the P. falciparum-infected
adults had no signs or symptoms of malaria when the
blood smear was prepared and they were not treated
with anti-malarial drugs (the blood smear was not read
immediately). The Ethics Committee of the Faculty of
Medicine, Pharmacy, and Odonto-Stomatology at the
University of Bamako, Mali approved this study. De-
identified specimens were obtained from this study for
immunological analyses. Written, informed consent was
obtained from all study participants.
U.S. blood donors
Peripheral blood mononuclear cells (PBMCs) from eight
healthy adult blood bank donors in the U.S. were also ana-
lysed. Demographic and travel history data were not avail-
able from these anonymous donors but prior P. falciparum
exposure is unlikely. Blood samples were obtained for re-
search use after written informed consent was obtained
from all study participants enrolled in a protocol
approved by the Institutional Review Board of the Na-
tional Institute of Allergy and Infectious Diseases, NIH
(protocol # 99-CC-0168).
PBMC isolation, cryopreservation, and recovery
Malian blood samples were drawn by venipuncture into
sodium citrate-containing cell preparation tubes (BD,
Vacutainer CPT Tubes). PBMCs were isolated according
to the manufacturer's instructions and frozen in foetal
bovine serum (FBS) (Gibco, Grand Island, NY) contain-
ing 7.5% dimethyl sulfoxide (DMSO; Sigma-Aldrich, St.
Louis, MO). U.S. blood samples were drawn into hepari-
nized tubes (BD) and PBMC were isolated from whole
blood by Ficoll-Hypaque density gradient centrifugation
(Amersham Biosciences) according to the manufacturer's
instructions, and frozen in same conditions as Malian
samples. PBMCs were kept at −80°C for 24 hours using
freezing containers (VWR International) to control the
rate of freezing and then transferred to liquid nitrogen.
For analysis, PBMCs were rapidly thawed in a 37°C water
bath, washed first in PBS with 10% heat-inactivated FBS
and then in complete RPMI (RPMI 1640 with L-glutamine
supplemented with 10% heat-inactivated FBS, penicillin/
streptomycin 10,000 μg/ml, and 50 μM β-mercaptoethanol
(all from GIBCO, Invitrogen)).
B cell phenotypic analysis
PBMCs were washed in PBS with 4% heat-inactivated
FBS and incubated for 30 min at 4°C with mouse
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CD10 APC (HI10a) and CD20 APC-H7 (L27) (BD Bios-
ciences); CD19 PerCP-Cy5.5 (SJ25C1) and CD27 PE-Cy7
(O323) (eBioscience) and CD21 FITC (BL13) (Beckman
Coulter). Flow cytometry was performed with a BD™
LSR II Table flow cytometer (BD Biosciences) and data
were analysed using FlowJo software (Tree Star, Inc).
Measurement of peripheral blood P. falciparum
parasitaemia
Thick blood smears were stained with Giemsa and counted
against 300 leukocytes. Plasmodium falciparum densities
were recorded as the number of asexual parasites/μl of
whole blood based on an average leukocyte count of
7,500/μl. Each smear was evaluated separately by two
expert microscopists. Any discrepancies were resolved
by a third expert microscopist.
Statistical analysis
Data were analysed using GraphPad Prism 5 for Mac OS
X (GraphPad Software, version 5.0d). The non-parametric
Mann–Whitney test was used to compare continuous
variables between groups, and the Fisher's exact test was
used to compare categorical variables. For all tests, two-
tailed p values were considered significant if ≤0.05.
Results and discussion
Study subject characteristics
Twenty-five Fulani adults and 25 Dogon adults living in
the same village in Mali were included in this study.
Demographic and P. falciparum infection status data
are shown in Table 1 according to ethnic group. The
average age of the Fulani participants was 38.9 years
(range: 19–57 years) and 60% were female. The average
age of the Dogon participants was 38.0 years (range:
21–57 years) and 36% were female. At the time of the
venous blood collection, four Fulani (16%) and nine
Dogon (36%) were infected with P. falciparum by blood-
smear. Of those who were infected, the mean parasite
densities for the Fulani and Dogon were 2281.25 ± 1285.9Table 1 Age and gender distribution of participants by
ethnic group, parasite prevalence and parasite density at
the time of venous blood collection
Fulani Dogon P value
Number of subjects 25 25
Age-range (years) 21 - 57 22 - 57
Age-median (years) 37 38 ns 0.777
Gender distribution
(% women)
36 52 ns 0.138
Parasite prevalence (%) 16 36 ns 0.196
Parasite density +/−
SD (parasites/μl)
2281.25 ± 1285.9 2563.5 ± 1652.9 ns 0.766and 2563.5 ± 1652.9 asexual parasites/μl, respectively. All
participants were afebrile and asymptomatic at the time
of venous blood draw.
Phenotypic analysis of B cell subsets
The proportion of various B cell subsets in the periph-
eral blood of Fulani (n = 25) and Dogon (n = 25) adults
was compared by flow cytometry analysis of thawed
PBMCs, which had been collected at the peak of the
malaria season. These data were compared to B cell pro-
files of P. falciparum-naïve U.S. adults (n = 8).
A panel of fluorophore-conjugated antibodies specific
for CD10, CD19, CD20, CD21 and CD27 allowed for the
quantification of immature B cells (CD10+CD19+), naïve
B cells (CD10-CD19+CD20+CD21+CD27-), plasma cells/
plasma blasts (CD10-CD19+CD20-CD21-CD27+), clas-
sical MBCs (CD10-CD19+CD20-CD21+CD27+), activated
MBCs (CD10-CD19+CD20+CD21-CD27+) and atypical
MBCs (CD10-CD19+CD20+CD21-CD27-). Figure 1 shows
the gating strategy used to identify these B cell subpopu-
lations in a representative Fulani adult.
As a percentage of total lymphocytes, the mean per-
centage of total B cells (CD19+) was similar in Fulani
and Dogon adults (Figure 2A; Fulani: 13.6% [95% CI:
11.3 – 15.94]; Dogon: 14.2% [95% CI: 11.86 – 16.60], but
significantly lower than U.S. adults (Figure 2A; U.S.:
34.8% [95% CI: 26.56 – 42.96]; p< 0.001 versus Fulani
and Dogon). As a percentage of total B cells, the mean
percentages of immature B cells (Figure 2B; Fulani:
2.066% [95% CI: 1.452 – 2.679]; Dogon: 1.514% [95% CI:
1.2 – 1.829] and naïve B cells (Figure 2C; Fulani: 35.6%
[95% CI: 31.55 – 39.63]; Dogon: 39.4% [95% CI: 35.33 –
43.52] were also similar between the Fulani and Dogon,
but lower than U.S. adults (Figure 2B and 2C; U.S. im-
mature B cells: 5.023% [95% CI: 3.212 – 6.833]; U.S.
naïve B cells: 79.6% [95% CI: 66.53 – 92.65]; p< 0.001
for all comparisons). The mean percentage of plasma
cells/plasma blasts was also similar among Fulani and
Dogon adults (Figure 2D; Fulani: 1.95% [95% CI: 1.537 –
2.371]; Dogon: 2.0% [95% CI: 1.616 – 2.391], but higher
than U.S. adults (Figure 2D; U.S.: 0.3188% [95% CI:
0.1656– 0.4720]; p< 0.001 versus Fulani and Dogon).
The mean percentage of classical MBCs did not differ
significantly across the three groups (Figure 2E; Fulani:
25.08% [95% CI: 20.84 – 29.32]; Dogon: 22.97% [95% CI:
19.3 – 26.64]; U.S.: 16.12% [95% CI: 6.25 – 25.99]). Inter-
estingly, the mean percentage of activated MBCs was sig-
nificantly higher in Fulani versus Dogon adults
(Figure 2F; Fulani: 11.07% [95% CI: 9.317 – 12.82];
Dogon: 8.31% [95% CI: 6.378 – 10.23]; p = 0.016) and
both groups were higher than U.S. adults (Figure 2F; U.S.:
1.32% [95% CI: 0.011 – 2.63]; p< 0.001 versus Fulani and
Dogon). Finally, the mean percentage of atypical MBCs
was similar among Fulani and Dogon adults (Figure 2G;
Figure 1 Flow cytometry gating strategies for B cell phenotyping. FACS plots of B cell subsets of a representative Fulani adult. Within the
CD19+ gate shown in gray (A), the B cell subpopulations are defined as follows: immature (CD10+) shown in purple (B); plasma cells/plasma
blasts (CD20- CD21- CD27+); shown in blue (C); activated MBCs (CD10- CD20+ CD21- CD27+), classical MBCs (CD10- CD20+ CD21+ CD27+), atypical
MBCs (CD10- CD20+ CD21- CD27-) and naïve B cells (CD10- CD20+ CD21+ CD27-) shown in orange, pink, blue and green respectively (D).
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CI: 25.06 – 33.55], but higher than U.S. adults (Figure 2G;
U.S.: 3.0% [95% CI: -0.21 - 6.164]; p< 0.001 versus Fulani
and Dogon).
Together these data indicate that the overall distribu-
tion of B cell subsets is similar among the Fulani and
Dogon adults in this study population, with the excep-
tion of activated MBCs, which were increased among the
Fulani. Activated MBCs are known to promote signaling
cascades that induce their differentiation into antibody
secreting cells, thus a higher level of activated MBCs
among the Fulani is consistent with their propensity to-
ward higher antibody responses and decreased malaria
susceptibility [2,6].
The higher percentage of atypical and activated MBCs
in Fulani and Dogon Malians versus U.S. adults is con-
sistent with previous studies of P. falciparum-exposed
individuals at separate study sites in Mali [11], in The
Gambia [15], and Peru [10]. These data provide further
evidence that an increase in atypical MBCs is a
generalizable finding among P. falciparum-exposed
populations. The specificity and function of atypicalMBCs in the context of P. falciparum transmission
remains to be determined. It is possible that atypical
MBCs contribute to protection against malaria by regulat-
ing the host immune response; on the other hand, it is also
conceivable that functional exhaustion of P. falciparum-
specific MBCs through repeated infections contributes
to the inefficient acquisition and relatively rapid loss of
P. falciparum-specific MBCs and long-lived antibodies
which has been observed in areas of intense P. falciparum
transmission [16,17].
Also consistent with previous observations [10,11,16],
it was found that relative to U.S. volunteers, Malian
adults had a lower proportion of immature and naïve B
cells and a higher proportion of activated MBCs and
plasma cells/plasmablasts, possibly reflecting greater cu-
mulative immunological experience.
To assess whether concurrent asymptomatic P. falciparum
infection was associated with alterations in B cell sub-
sets, Fulani and Dogon adults were stratified by
whether or not the thick blood smears were positive for
P. falciparum infection at the time of blood collec-
tion. Plasmodium falciparum infection status was not
Figure 2 B cell populations of Fulani, Dogon and U.S. volunteers. PBMCs from Fulani, Dogon and U.S. volunteers were analysed by
flow-cytometry. Quantitation of total B cells (CD19+) (A), immature B cells (CD10+ CD19+) (B), naïve B cells (CD21+ CD27-) (C), plasma cells/plasma
blasts (CD20- CD21-) (D), classical MBCs (CD21+ CD27+) (E), activated MBCs (CD21- CD27+) (F) and atypical MBCs (CD21- CD27-) (G). N = 25 for Fulani
and Dogon volunteers and n=8 for U.S. volunteers. Lines represent mean % of live lymphocytes; error bars indicate SD (* p < 0.05; ** p < 0.001).
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tages of total B cells (Figure 3A). However, P. falciparum
infection was associated with a lower percentage of im-
mature B cells among the Fulani (Figure 3B; Fulani un-
infected: 2.336% [95% CI: 1.656 – 3.016]; Fulani
infected: 0.7803% [95% CI: 0.167 – 1.393]; p = 0.005),
but not the Dogon (Figure 3B; Dogon uninfected:
1.505% [95% CI: 1.029 – 1.982]; Dogon infected: 1.428%
[95% CI: 0.9207 – 1.935]). Plasmodium falciparum in-
fection was not associated with significant differences in
the percentage of naïve B cells in either ethnic group
(Figures 3C), while P. falciparum infection was associatedwith a significantly higher percentage of plasma cells/
plasma blasts in the Fulani (Figure 3D; Fulani uninfected:
1.71% [95% CI: 1.33 – 2.08]; Fulani infected: 3.3% [95% CI:
1.788 – 4.744]; p = 0.011), but not the Dogon (Figure 3D;
Dogon uninfected: 2.17% [95% CI: 1.549 – 2.799];
Dogon infected: 1.81% [95% CI: 1.276 – 2.536]). The
higher percentage of antibody-secreting plasma cells
observed in P. falciparum-infected Fulani adults is con-
sistent with the higher levels of P. falciparum-specific
antibodies observed by others in this ethnic group [2-4].
Asymptomatic P. falciparum infection was not asso-
ciated with significant changes in the percentages of
Figure 3 B cell populations from P. falciparum-infected Fulani and Dogon volunteers. PBMCs from P. falciparum-infected Fulani, Dogon and U.
S. volunteers were analyzed by flow-cytometry. Quantitation of total B cells (CD19+) (A), immature B cells (CD10+ CD19+) (B), naïve B cells (CD21+ CD27-)
(C), plasma cells/plasma blasts (CD20- CD21-) (D), classical MBCs (CD21+ CD27+) (E), activated MBCs (CD21- CD27+) (F), and atypical MBCs (CD21- CD27-)
(G). N= 4 infected Fulani; n= 9 infected Dogon. Lines represent mean % of live lymphocytes; error bars indicate SD (* p < 0.05; ** p < 0.01).
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group (Figures 3E–G).
Conclusion
It is well established that the Fulani ethnic group is
less susceptible to malaria compared to other sympatric
ethnic groups in West Africa, but the mechanisms
underlying this observation remain obscure. The
enhanced P. falciparum-specific antibody response of
the Fulani group is among the more consistent obser-
vations, which led us to investigate potential differences
in B cell subpopulations. Indeed, the Fulani had ahigher percentage of activated MBCs compared to the
Dogon, and that P. falciparum infection was associated
with higher percentage of antibody-secreting cells
among the Fulani but not the Dogon. These results
serve as a basis for further studies of the B cell biology
that underlies the association between Fulani ethnicity
and decreased malaria susceptibility.
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